Prospekta 100 tablets

- cognitive impairment of various origins, including after acute cerebrovascular accidents;
- asthenic conditions in the post-infectious period, including after coronavirus infection (COVID-19). Prospecta® is indicated for use in children aged 7 years and older for the treatment of attention deficit hyperactivity disorder.

The tablet is not intended for dividing.
Oral administration. 1-2 tablets per dose. Take the medication without meals (between meals or 15 minutes before meals or liquids). Keep the tablets in the mouth without swallowing until completely dissolved.
For the treatment of cognitive impairment, including after acute cerebrovascular accidents
Take 2 tablets 2 times daily. The course of treatment is 6 months; if necessary, the course of treatment can be repeated after 1-2 months.
For the treatment of post-infectious asthenic conditions
Take 1 tablet 2 times daily. The course of treatment is 1 month; if necessary, the course of treatment can be repeated after 1-2 months.
If there is no improvement within 4 weeks of starting treatment, consult a doctor.
For the treatment of attention deficit hyperactivity disorder
Take 1 tablet 2 times daily (at approximately the same time each day). The course of treatment is 8 weeks; if necessary, the course of treatment can be repeated after 1-2 months.

Active ingredient: affinity-purified, modified antibodies to the brain-specific protein S-100 - 10,000 IMU*.
Excipients: lactose monohydrate (lactose), microcrystalline cellulose, magnesium stearate.
* IMU - action modifying units.